A self-assessment scale has been developed and found to be a reliable instrument for detecting states of depression and anxiety in the setting of an hospital medical outpatient clinic. The anxiety and depressive subscales are also valid measures of severity of the emotional disorder. It is suggested that the introduction of the scales into general…
Acta Psychiatrica Scandinavica Template
Write in a clean editor, then format for Acta Psychiatrica Scandinavica in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Acta Psychiatrica Scandinavica format
Acta Psychiatrica Scandinavica is a peer-reviewed journal published by Wiley, covering Schizophrenia research and treatment, Bipolar Disorder and Treatment, Mental Health and Psychiatry.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Acta Psychiatrica Scandinavica 12 (3): 45–58.
Formats any DOI in Acta Psychiatrica Scandinavica style. No sign-up. |
| Publishes research in | Schizophrenia research and treatment Bipolar Disorder and Treatment Mental Health and Psychiatry Child and Adolescent Psychosocial and Emotional Development Treatment of Major Depression |
| ISSN | 0001-690X |
| Citation impact (2-yr) | 3.51 |
| h-index | 240 |
| i10-index | 7,392 |
| Total citations | 533,192 |
| Article processing charge | $4,430 |
| Top institutions publishing here | Karolinska Institutet |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Acta Psychiatrica Scandinavica per year
Citation impact of Acta Psychiatrica Scandinavica by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Acta Psychiatrica Scandinavica
SUMMARY A modification of an earlier rating scale for extrapyramidal system disturbance is described, and evidence for the validity and reliability of the scale is presented. The usefulness of the scale in studies of neuroleptic drugs is discussed. By its application it is possible to quantify extrapyramidal side effects and to separate them into four…
OBJECTIVE: To describe the 12-month and lifetime prevalence rates of mood, anxiety and alcohol disorders in six European countries. METHOD: A representative random sample of non-institutionalized inhabitants from Belgium, France, Germany, Italy, the Netherlands and Spain aged 18 or older (n = 21425) were interviewed between January 2001 and August 2003. DSM-IV disorders were assessed…
OBJECTIVE: To quantify the risk of developing dementia in those with mild cognitive impairment (MCI). METHOD: Meta-analysis of inception cohort studies. RESULTS: Forty-one robust cohort studies were identified. To avoid heterogeneity clinical studies, population studies and clinical trials were analysed separately. Using Mayo defined MCI at baseline and adjusting for sample size, the cumulative proportion…